Telepathology slide scanner market seen reaching $2.91 billion by 2030

The telepathology slide scanner market is projected to grow from $1.5 billion in 2025 to $1.72 billion in 2026, then nearly double again to $2.91 billion by 2030. Demand is rising as hospitals and labs lean harder on digital pathology, remote diagnostics and AI-assisted analysis.

Why it matters: - Telepathology slide scanners help pathologists review tissue and biopsy samples remotely, which can speed diagnosis and support expert collaboration. - The market is being pulled by rising chronic disease rates, cancer screening needs, and pressure on healthcare systems facing pathologist shortages. - Demand also reflects broader shifts toward digital labs, automation, and precision medicine.

What happened: - The Business Research Company released its 2026 telepathology slide scanner market report covering market size, trends, and global forecasts for 2026-2035. - The report pegs the market at $1.5 billion in 2025 and $1.72 billion in 2026. - The report projects the market will reach $2.91 billion by 2030. - The forecast implies a 14.3% CAGR from 2025 to 2026 and a 14.0% CAGR through 2030. - A free sample report and the full market report are available online.

The details: - Telepathology slide scanners are digital imaging systems that capture high-resolution images of pathology slides. - The devices convert glass slides into digital formats that can be shared and examined remotely. - The technology improves diagnostic precision, speeds up slide review, and enables real-time collaboration. - Past market growth has been supported by shortages of pathologists, higher cancer diagnosis rates, digital transformation in laboratories, demand for remote consultations, and imaging advances. - Future growth is expected to be supported by wider AI adoption, broader telepathology use, global collaboration among pathologists, workflow automation, and precision medicine. - Key trends named in the report include whole slide digital imaging, remote pathology diagnostics, AI-supported slide analysis, high-throughput scanning, and cloud-based pathology solutions. - Chronic diseases such as cardiovascular disease, diabetes, cancer, and respiratory disorders are increasing demand for these scanners. - The aging population is adding to that burden because older adults face lower immunity, slower tissue repair, and greater vulnerability to illness. - The CDC reported in April 2025 that 76.4% of US adults, or about 194 million people, had at least one chronic condition in 2023. - The report says North America held the largest global market share in 2025. - The Asia-Pacific region is expected to post the fastest growth during the forecast period. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Between the lines: - The report points to a market moving from niche digital pathology toward mainstream clinical workflow. - AI and cloud tools look set to become the main differentiators as labs seek faster interpretation and wider access to specialists. - North America’s lead suggests early adoption, while faster Asia-Pacific growth signals expanding healthcare digitization beyond mature markets.

What's next: - The company expects continued adoption of AI-enabled diagnostics and remote pathology tools through 2030. - The report also highlights new 2026 features such as market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics, and updated graphics and tables. - The Business Research Company directs readers to contact Saumya Sahay for more information and lists its website and social channels in the release.

The bottom line: - Telepathology slide scanners are moving into a high-growth phase as digital pathology, AI, and remote care reshape how tissue samples are reviewed.